Michael Klimas

Indi Molecular has appointed Michael Klimas its senior vice president of strategy and technical business development. He most recently was Merck Research Laboratories' executive director translational biomarker immuno-oncology and cardiometabolic lead. He started his career at AstraZeneca in neuroscience drug discovery, and he was a founding member of GE Medical Systems' molecular imaging strategy and business development effort.